Acurx Pharmaceuticals, Inc. Liquidation Value Calculator
Acurx Pharmaceuticals, Inc.
Current Price: $2.01 (as of 2026-04-24)
Loading calculator data...
Advanced: All 75 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash total | $7.56M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$7.56M | USD | ||
| current_liabilities | ||||
| Employee Related Liabilities Current total EmployeeRelatedLiabilitiesCurrent |
$39,011 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$2.42M | USD | ||
| liabilities_total | ||||
| Liabilities total | $2.42M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
2.3M | shares | ||
Unmapped Tags (67)
| Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent | $48,417 | USD | ||
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $2.42M | USD | ||
| Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent | $6,802 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $80.55M | USD | ||
| Assets Assets | $7.69M | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $250.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $2.35M | shares | ||
| Common Stock Value CommonStockValue | $2,348 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $18.79M | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $10.47M | USD | ||
| Deferred Tax Assets Other DeferredTaxAssetsOther | $41,905 | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch | $331,671 | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $18.79M | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $125,445 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $7.69M | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-75.29M | USD | ||
| Stockholders Equity StockholdersEquity | $5.27M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $1.25M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $3.85M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $4.56M | USD | ||
| Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables | $-2,710 | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $-408,779 | USD | ||
| Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense | $-15,105 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $10.64M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-6.79M | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $1.36M | USD | ||
| Share Based Compensation ShareBasedCompensation | $1.25M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $209,199 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $91 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $33,775 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | $12 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $227,775 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $88 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $16 | USD/shares | ||
| Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit | $0 | USD | ||
| Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment | $3.38M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-5 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-5 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $6.26M | USD | ||
| Income Taxes Receivable IncomeTaxesReceivable | $48,417 | USD | ||
| Net Income Loss NetIncomeLoss | $-7.97M | USD | ||
| Operating Expenses OperatingExpenses | $8.09M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-8.09M | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $85,018 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.83M | USD | ||
| Accrued Professional Fees Current AccruedProfessionalFeesCurrent | $63,782 | USD | ||
| Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding | $922,879 | shares | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | segment | ||
| Operating Loss Carryforwards OperatingLossCarryforwards | $33.50M | USD | ||
| Profit Loss ProfitLoss | $-7.97M | USD | ||
| Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices | $322,319 | USD | ||
| Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue | $1,040 | USD | ||
| Tax Credit Carryforward Amount TaxCreditCarryforwardAmount | $300,000 | USD | ||
| Unrecognized Tax Benefits UnrecognizedTaxBenefits | $0 | USD | ||
| ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired | $2.20M | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.